New hope for young adults whose obesity resisted lifestyle changes
NCT ID NCT05574439
Summary
This study is testing whether a medication called semaglutide can help young adults (ages 18-28) who have obesity that did not respond well to intensive lifestyle programs when they were children. About 180 participants will receive either the medication or a placebo for over a year, alongside lifestyle advice. The main goal is to see if the drug leads to a greater reduction in body mass index (BMI) compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY, ADOLESCENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Holbæk University Hospital
NOT_YET_RECRUITINGHolbæk, Region Zeeland, 4300, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Copenhagen, Department of Biomedical Sciences
RECRUITINGCopenhagen, 2200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.